Syneos Health Completes Acquisition of Synteract
December 10, 2020 08:59 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it has completed the...
Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event
December 07, 2020 17:18 ET
|
Syneos Health, Inc.
Unique Product Development Model Delivers Accelerated Growth Presentation Begins at 9:00 A.M. ET on Tuesday, December 8 MORRISVILLE, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Syneos Health®...
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
December 03, 2020 08:49 ET
|
Syneos Health, Inc.
BOSTON and MORRISVILLE, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization and ConcertAI, the leader in oncology...
Syneos Health Announces Secondary Offering of Common Stock
December 01, 2020 16:21 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Announces Closing of Offering of $600.0 Million of Senior Notes Due 2029
November 24, 2020 18:07 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Announces Upsizing and Pricing of Offering of $600.0 Million of Senior Notes Due 2029
November 18, 2020 18:52 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Names Larry A. Pickett Jr. Chief Information & Digital Officer
November 17, 2020 08:40 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Larry A....
Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020
November 16, 2020 08:43 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health to Present at Upcoming Investor Conferences
November 02, 2020 17:20 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health Reports Third Quarter 2020 Results
October 29, 2020 06:13 ET
|
Syneos Health, Inc.
Highlights Announced agreement to acquire Synteract, a mid-sized, full-service CRO focused on the fast growing emerging biopharma sector.GAAP revenue of $1,099.0 million for the three months ended...